Baron Counseling Services Llc | |
18441 Nw 2nd Ave Sutie 116, North Tower Miami FL 33169-4517 | |
(786) 320-8722 | |
(786) 320-6891 |
Full Name | Baron Counseling Services Llc |
---|---|
Speciality | Community/Behavioral Health |
Location | 18441 Nw 2nd Ave, Miami, Florida |
Authorized Official Name and Position | Darlise Baron (OWNER) |
Authorized Official Contact | 7868537192 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Baron Counseling Services Llc 18441 Nw 2nd Ave Sutie 116, North Tower Miami FL 33169-4517 Ph: (786) 853-7192 | Baron Counseling Services Llc 18441 Nw 2nd Ave Sutie 116, North Tower Miami FL 33169-4517 Ph: (786) 320-8722 |
NPI Number | 1063844660 |
---|---|
Provider Enumeration Date | 08/06/2013 |
Last Update Date | 07/20/2021 |
Certification Date | 07/20/2021 |
Medicare PECOS PAC ID | 3779883442 |
---|---|
Medicare Enrollment ID | O20151202000893 |
News Archive
Porvair Sciences has announced the MiniVap™ Gemini - an all new entry-level product designed to remove the solvent from two microplates simultaneously.
Australians consider medical research to be a more important priority for funding and resources than tax cuts and border protection, a new poll has found.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
University of Adelaide research has shown for the first time that obesity directly causes electrical abnormalities of the heart.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1063844660 | NPI | - | NPPES |
024028900 | Medicaid | FL |
Provider Name | Darlise Baron |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1548327828 PECOS PAC ID: 7416257191 Enrollment ID: I20151202001385 |
News Archive
Porvair Sciences has announced the MiniVap™ Gemini - an all new entry-level product designed to remove the solvent from two microplates simultaneously.
Australians consider medical research to be a more important priority for funding and resources than tax cuts and border protection, a new poll has found.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
University of Adelaide research has shown for the first time that obesity directly causes electrical abnormalities of the heart.
› Verified 9 days ago
Provider Name | Clicile Pierre |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1295178705 PECOS PAC ID: 6901106699 Enrollment ID: I20151202001547 |
News Archive
Porvair Sciences has announced the MiniVap™ Gemini - an all new entry-level product designed to remove the solvent from two microplates simultaneously.
Australians consider medical research to be a more important priority for funding and resources than tax cuts and border protection, a new poll has found.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
University of Adelaide research has shown for the first time that obesity directly causes electrical abnormalities of the heart.
› Verified 9 days ago
News Archive
Porvair Sciences has announced the MiniVap™ Gemini - an all new entry-level product designed to remove the solvent from two microplates simultaneously.
Australians consider medical research to be a more important priority for funding and resources than tax cuts and border protection, a new poll has found.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
University of Adelaide research has shown for the first time that obesity directly causes electrical abnormalities of the heart.
› Verified 9 days ago
Future Care Solution Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3911 Sw 67th Ave, Miami, FL 33155 Phone: 305-740-6960 Fax: 305-740-6959 | |
Kids Behaviors Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14554 Sw 143rd Pl, Miami, FL 33186 Phone: 786-523-2414 | |
Deborah M. Thevenin, Ph.d., Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7685 Sw 104th St, Suite 100, Miami, FL 33156 Phone: 305-666-8000 Fax: 305-666-4311 | |
Miami-dade County Community Action And Human Services Department Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 Nw 79th St, Miami, FL 33150 Phone: 305-751-4342 Fax: 305-759-2763 | |
Luzmila Victorero Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 Sw 77th Ave, Miami, FL 33144 Phone: 786-406-4933 | |
Adaga Therapy Group Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2926 Sw 145th Ave, Miami, FL 33175 Phone: 305-301-1856 | |
Advance Behavior Coalition Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14531 Sw 157th Ct, Miami, FL 33196 Phone: 305-733-9005 |